These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11004631)
1. Pilomatricomas contain activating mutations in beta-catenin. Chan EF J Am Acad Dermatol; 2000 Oct; 43(4):701-2. PubMed ID: 11004631 [No Abstract] [Full Text] [Related]
2. [Beta-catenin mutations in a common skin cancer: pilomatricoma]. Durand M; Molès JP Bull Cancer; 1999 Sep; 86(9):725-6. PubMed ID: 10519964 [TBL] [Abstract][Full Text] [Related]
3. [Principal features of multiple pilomatricoma and its association with beta-catenin mutation]. Faviou E; Baltogiannis N; Cigliano B; D'Agostino S An Pediatr (Barc); 2005 Jun; 62(6):593-4; author reply 594. PubMed ID: 15927129 [No Abstract] [Full Text] [Related]
4. A common human skin tumour is caused by activating mutations in beta-catenin. Chan EF; Gat U; McNiff JM; Fuchs E Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393 [TBL] [Abstract][Full Text] [Related]
5. Low frequency of beta-catenin gene mutations in pilomatricoma. Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848 [TBL] [Abstract][Full Text] [Related]
6. beta-Catenin gene mutation in human hair follicle-related tumors. Kajino Y; Yamaguchi A; Hashimoto N; Matsuura A; Sato N; Kikuchi K Pathol Int; 2001 Jul; 51(7):543-8. PubMed ID: 11472567 [TBL] [Abstract][Full Text] [Related]
7. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674 [TBL] [Abstract][Full Text] [Related]
8. beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles. Moreno-Bueno G; Gamallo C; Pérez-Gallego L; Contreras F; Palacios J Br J Dermatol; 2001 Oct; 145(4):576-81. PubMed ID: 11703283 [TBL] [Abstract][Full Text] [Related]
9. The first case of multiple pilomatricomas caused by somatic mutations of CTNNB1 without any associated disorder. Akasaka E; Nakano H; Fukui T; Korekawa A; Aizu T; Sawamura D J Dermatol Sci; 2017 Nov; 88(2):259-260. PubMed ID: 28651848 [No Abstract] [Full Text] [Related]
10. Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype. Rübben A; Wahl RU; Eggermann T; Dahl E; Ortiz-Brüchle N; Cacchi C PLoS One; 2020; 15(3):e0230003. PubMed ID: 32155193 [TBL] [Abstract][Full Text] [Related]
11. Familial multiple pilomatricomas showing clinical features of a giant mass without associated diseases. Do JE; Noh S; Jee HJ; Oh SH Int J Dermatol; 2013 Feb; 52(2):250-2. PubMed ID: 23347315 [No Abstract] [Full Text] [Related]
12. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715 [TBL] [Abstract][Full Text] [Related]
13. Rubinstein-Taybi syndrome with multiple pilomatricomas: The first case diagnosed by CREBBP mutation analysis. Rokunohe D; Nakano H; Akasaka E; Toyomaki Y; Sawamura D J Dermatol Sci; 2016 Sep; 83(3):240-2. PubMed ID: 27342041 [No Abstract] [Full Text] [Related]
14. beta-Catenin expression in the transitional cell zone of pilomatricoma. Park SW; Suh KS; Wang HY; Kim ST; Sung HS Br J Dermatol; 2001 Oct; 145(4):624-9. PubMed ID: 11703290 [TBL] [Abstract][Full Text] [Related]